Molybdenum-99 Production Center to be constructed in Russia
Ivan Kamenskih, the Rosatom Deputy Director-General, signed a permit for the building reconstruction of one of the nuclear center production sites, where the center will be located. The government expert review has confirmed the project documentation.
The extraction of medical isotope will be carried out on the «Argus-M» nuclear reactor basis. The «Argus-M» reactor has a natural safety — it shuts down itself in the event of an accident situation. The project can provide up to 30% of the medical isotopes market needs and bring Russia to the technological leaders in the production of molybdenum-99.
«The Molybdenum-99 Production Center creation is one of the most effective projects of the Rosatom State Corporation. The nuclear center has a firm intention to realize this project, because with it we connect not only civil areas of our activity, but also the development of a cluster of radiochemistry in the field of fundamental and applied science,» Valentin Kostyukov, the head of the All-Russian Scientific Research Institute of Experimental Physics, said.
The safety of the Production Center during the construction and operation is confirmed. The production will be located at an industrial site remote from residential development and will not pose a danger to the population. Every 10 years there will be refuelling of the reactor. The construction is fully financed by the Rosatom State Corporation.
Argus reactor is a type of nuclear reactor in which soluble nuclear salts (usually uranium sulfateor uranium nitrate) are dissolved in water. The fuel is mixed with the coolant and the moderator.
This reactor, with 20 kW thermal output power, has been in operation since 1981 and has shown high indices of efficiency and safety. The reactor is mainly used as a neutron source for neutron activation analysis of geological samples.
Liked it? Share it! —